|
V60042
|
Carboxylesterase-IN-2
|
2764748-88-9 |
Carboxylesterase-IN-2 (compound 4u) is a potent Carboxylesterase Notum inhibitor (antagonist) with IC50 less than or equal to 10 nM. |
|
V18831
|
CRT-0105950
|
1661845-86-8 |
CRT0105950 is a potent LIMK inhibitor (antagonist) with IC50s of 0.3 nM and 1 nM for LIMK1 and LIMK2 inhibition, respectively. |
|
V12460
|
CYM-50769
|
1421365-63-0 |
CYM 50769 is a non-peptide selective antagonist of neuropeptide B/W receptor 1 (NPBWR1). |
|
V11837
|
EN106
|
757192-67-9 |
EN106 is a potent FEMIB inhibitor. |
|
V36344
|
GSK484 free base
|
1652629-23-6 |
GSK484 is a novel, potent, selective and reversible peptidylarginine deiminase 4 (PAD4) inhibitor which showes high affinity binding to PAD4 with IC50s of 50 nM in the absence of Calcium. |
|
V34671
|
Hexakis(p-bromophenoxy)cyclotriphosphazene
|
4376-72-1 |
Hexakis(p-bromophenoxy)cyclotriphosphazene is a useful chemical compound. |
|
V60054
|
HIF-2α Translation Inhibitor
|
882268-69-1 |
HIF-2α-IN-4 is a potent HIF-2α translation inhibitor (antagonist) with IC50 of 5 μM. |
|
V17133
|
IL-17 modulator 4
|
2446803-65-0 |
IL-17 modulator 4 is a precursor to IL-17 modulator 1 . |
|
V22210
|
IN04
|
838816-57-2 |
IN04, also know asMethyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate, is a novel and potent inhibitor of Leucine rich repeat kinase 1 (LRRK1), suppressing osteoclasts (OC) function with no effect on OC formation. |
|
V16229
|
KN 1022
|
205255-11-4 |
KN-1022 also known as1-Piperazinecarboxamide, 4-(6,7-dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)- is aBioactive molecules. |
|
V60064
|
Lecithins, egg
|
93685-90-6 |
Lecithins, egg is a novel and potent. |
|
V24834
|
OATD-01
|
2088453-21-6 |
OATD-01 is a novel, selective andhighly active CHIT1 (chitinase1, hAMCase IC50=9nM, hCHIT1 IC50=26nM) inhibitor with both an excellent PK profile in multiple species and selectivity against a panel of other off-targets. |
|
V34667
|
TH-263
|
313520-94-4 |
TH-263 is adiaryl sulfonamide derivativeused as anegative control for the type III allosteric LIM-kinase (LIMK) inhibitors TH-257, TH-255 and TH-251. |
|
V60041
|
WAY-116749
|
380872-69-5 |
WAY-116749 also name asEthyl 2-[[2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)acetyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate |
|
V60005
|
Follicle-stimulating hormone
|
146479-72-3 |
Follicle-stimulating hormone (FSH) is a heterodimeric glycoprotein expressed by gonadotrophs in the anterior pituitary. |
|
V7876
|
Ozagrel sodium
|
130952-46-4 |
Ozagrel (also known as OKY-046) sodium salt is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor. |
|
V17003
|
Lasmiditan succinate (COL144, LY573144)
|
439239-92-6 |
Lasmiditan succinate (COL-144, LY-573144) is a novel and selective 5-HT(1F) receptor agonist with Ki of 2.1 nM versus Ki of 1043 nM and 1357 nM at the 5-HT(1B) and 5-HT(1D) receptors, respectively. |
|
V11464
|
Cenobamate intermediate
|
1259059-71-6 |
Cenobamate intermediate is an intermediate used in the synthesis of cenobamate, which is medication is used to treat a certain type of seizure disorder (partial onset). |